FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, namely a combination of clopidogrel and ethylmethylhydroxypyridine. A composition on the basis of the combination is presented in the form of a solid pharmaceutical composition, namely in the form of capsules.
EFFECT: composition of clopidogrel and ethylmethylhydroxypyridine is promising for prevention and treatment of obesity, pathological cardiovascular conditions prevention of ischemic disorders with manifested atherosclerosis, suffered infarction, ischemic stroke, peripheral arterial disease.
2 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
| METHOD OF SYNTHESIS OF GAMMA-L-GLUTAMYLHISTAMINE, USE OF GAMMA-L-GLUTAMYLHISTAMINE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2141968C1 |
| METHOD OF PREVENTING LIPID EXCHANGE DISORDERS | 2009 |
|
RU2423123C1 |
| ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
| NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, USE AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2141483C1 |
| N-ACYL DERIVATIVES OF AMINOACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND APPLICATION AS HYPOLIPIDEMIC PREPARATIONS | 2005 |
|
RU2335495C2 |
